# Neurology (headache medicine) Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Thomas Jefferson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN005-SYN-TD
- Date: 1790-05-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Farida Haddad, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Nathaniel Beaumont-Ruiz, MD

## Reason for consultation

Recurrent disabling headaches since his twenties, in bouts of near-daily morning-onset attacks lasting weeks, in a 47-year-old cabinet secretary now in the seventh day of a bout. Please confirm the diagnosis and advise on acute and preventive treatment. **S**

## History

Mr. Jefferson, a 47-year-old cabinet secretary, is seen at the request of Dr. Beaumont-Ruiz with a 14-day headache diary. He has had headaches since about 20, coming in bouts that last from days to several weeks, every few years, often at times of heavy work. The present bout began three weeks ago. In the diary, headache came on 7 of 14 days, starting between nine and ten in the morning and lasting six to ten hours, throbbing and moderate to severe across the forehead and temples, worse with reading and climbing stairs, with light and noise sensitivity on every headache day and nausea on four. He has never had an aura. The last seven days have been free. Naproxen on four days helped partly. He stopped the combination analgesic at intake. He sleeps about six hours, drinks two cups of coffee a day and skips meals on busy days. **S**

## Examination

| System | Finding |
|---|---|
| General | Comfortable today; blood pressure 122/78, pulse 70 |
| Eyes | Fundi with sharp discs; visual fields full |
| Neurological | Cranial nerves, strength, sensation, reflexes, coordination and gait normal |
| Head and neck | Mild tenderness of the neck and shoulder muscles; temporal arteries normal |

BP 122/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 76.2 kg; BMI 21.3 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Beaumont-Ruiz's intake note and the 14-day diary. MIDAS 39 (grade IV) and HIT-6 66 at intake; PHQ-9 6, GAD-7 7, AUDIT-C 3. Blood pressure 122/78 and pulse 70 today. No laboratory tests or imaging have been done, and none are needed. 

## Assessment

1. **Migraine without aura, episodic, with bouts of near-daily attacks** (G43.009). ICHD-3 criteria are met: at least five attacks of 4 to 72 hours with throbbing, moderate to severe pain worsened by routine activity, nausea, and light and noise sensitivity, not better accounted for by another diagnosis. Tension-type headache does not cause this severity, nausea or disability, though neck tension may add to it. Cluster headache does not fit: his attacks last hours, come by day, and lack one-sided eye symptoms. Medication overuse headache is not present, since the combination analgesic was used on fewer than 10 days a month and has stopped. **S**
2. **Need for investigation** (G43.009). A long, stable pattern with a normal neurological examination and no red flags does not call for brain imaging or blood tests; imaging would be considered for a new or changed pattern, a sudden severe headache, neurological signs, fever or onset after 50. **S**
3. **Acute treatment** (G43.009). Naproxen alone gives partial relief. A triptan with an NSAID taken early in the attack is the most effective first choice; he has no cardiovascular contraindication. A gepant or lasmiditan is the alternative if a triptan fails or becomes unsuitable. Opioids and butalbital should be avoided: they work poorly for migraine and raise the risk of medication overuse headache. **S**
4. **Preventive treatment** (G43.009). Bouts bring 13 migraine days in four weeks with severe disability (MIDAS 39), which meets the 1785 American Headache Society criteria for offering prevention. Propranolol is well established and inexpensive, and suits his normal blood pressure and lack of asthma. Topiramate can slow word-finding and concentration, and amitriptyline can cause morning drowsiness, both poor fits for his work. The 1788 AHS position statement makes a CGRP monoclonal antibody a first-line option, while the 1789 ACP guideline places it after the first-line oral preventives; after discussing both, he chose propranolol first, with an antibody as the next step. **S**
5. **Old right wrist injury** (M25.631). Neck and shoulder tension from long writing with a painful wrist may add to his headaches; hand therapy, a splint and dictation are worth doing. **S**

## Recommendations

1. Sumatriptan 100 mg with naproxen 500 mg early in an attack, with a second sumatriptan after two hours if needed; no more than nine triptan days a month.
2. Propranolol extended-release 80 mg each evening, raised to 120 mg at four weeks if pulse and blood pressure allow; judge the effect at two to three months, seeking at least half as many migraine days.
3. A CGRP monoclonal antibody if propranolol is not tolerated or does not work.
4. Keep acute medicine to two days a week or fewer, count the days in the diary, and avoid opioids, butalbital and combination products with caffeine.
5. No brain imaging unless the pattern changes or red flags appear.
6. For an attack lasting more than 72 hours, or a bout of daily attacks that the plan does not control, call the clinic for a short scheduled bridge (naproxen twice daily for up to five days) or treatment in clinic, rather than daily triptans or extra analgesics.
7. A fixed wake time, regular meals, steady caffeine, daily walks, regular breaks from reading, and hand therapy and dictation for the wrist.
8. PHQ-9 four to six weeks after starting propranolol, since beta-blockers can affect mood in some people.

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Communication

Discussed with Dr. Beaumont-Ruiz, who saw him the same day. The diagnosis and plan were explained to Mr. Jefferson, who asked careful questions about how each medicine works and chose propranolol after weighing the options. **S**

## Follow-up

Dr. Beaumont-Ruiz continues care at four weeks and three months; headache medicine will see him again if prevention fails, the pattern changes, or an antibody is needed. **S**

## Guideline basis

- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018), International Headache Society (Cephalalgia 2018;38(1):1-211)
- The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021), American Headache Society (Headache 2021;61(7):1021-1039)
- Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024), American Headache Society (Headache 2024;64(4):333-341)
- The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice (2019), American Headache Society (Headache 2019;59(1):1-18)
- Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025), American College of Physicians (Annals of Internal Medicine 2025;178(4):571-578)
- Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025), American College of Physicians (Annals of Internal Medicine 2025;178(3):426-433)
- Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013), American Headache Society (Headache 2013;53(10):1651-1659)
